A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis

References

• Chung BK, Karlsen TH, Folseraas T. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1390–1400. doi:10.1016/j.bbadis.2017.08.020
   PubMed Web of Science ®Google Scholar
• Massarweh NN, El-Serag HB. Epidemiology of Hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729245. doi:10.1177/1073274817729245
   Web of Science ®Google Scholar
• Paradis V, Zucman-Rossi J. Pathogenesis of primary liver carcinomas. J Hepatol. 2023;78(2):448–449. doi:10.1016/j.jhep.2022.05.037
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Sia D, Villanueva A, Friedman SL, Llovet JM. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 2017;152(4):745–761. doi:10.1053/j.gastro.2016.11.048
   PubMed Web of Science ®Google Scholar
• Kuper H, Ye W, Broomé U, et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology. 2001;34(4 Pt 1):714–718. doi:10.1053/jhep.2001.28233
   PubMedGoogle Scholar
• Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72(5):1605–1616. doi:10.1002/hep.31173
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015;62(6):1723–1730. doi:10.1002/hep.28123
   PubMed Web of Science ®Google Scholar
• Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65(8):1017–1025. doi:10.1016/j.metabol.2016.01.012
   PubMed Web of Science ®Google Scholar
• Satriano L, Lewinska M, Rodrigues PM, Banales JM, Andersen JB. Metabolic rearrangements in primary liver cancers: cause and consequences. Nat Rev Gastroenterol Hepatol. 2019;16(12):748–766. doi:10.1038/s41575-019-0217-8
   PubMed Web of Science ®Google Scholar
• Barouki R, Samson M, Blanc EB, et al. The exposome and liver disease - how environmental factors affect liver health. J Hepatol. 2023;79(2):492–505. doi:10.1016/j.jhep.2023.02.034
   PubMed Web of Science ®Google Scholar
• Gentile D, Donadon M, Lleo A, et al. Surgical treatment of Hepatocholangiocarcinoma: a systematic review. Liver Cancer. 2020;9(1):15–27. doi:10.1159/000503719
   PubMed Web of Science ®Google Scholar
• Ronot M, Nahon P, Rimola J. Screening of liver cancer with abbreviated MRI. Hepatology. 2023;78(2):670–686. doi:10.1097/hep.0000000000000339
   PubMed Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases. Hepatology. 2018;68(2):723–750. doi:10.1002/hep.29913
   PubMed Web of Science ®Google Scholar
• Singal AG, Conjeevaram HS, Volk ML, et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev. 2012;21(5):793–799. doi:10.1158/1055-9965.Epi-11-1005
   PubMed Web of Science ®Google Scholar
• Singal AG, Hoshida Y, Pinato DJ, et al. International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma. Gastroenterology. 2021;160(7):2572–2584. doi:10.1053/j.gastro.2021.01.233
   PubMed Web of Science ®Google Scholar
• Yang JD, Kim WR. Surveillance for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10(1):16–21. doi:10.1016/j.cgh.2011.06.004
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.125
   PubMed Web of Science ®Google Scholar
• Deatherage BL, Cookson BT. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun. 2012;80(6):1948–1957. doi:10.1128/iai.06014-11
   PubMed Web of Science ®Google Scholar
• Stanly C, Fiume I, Capasso G, Pocsfalvi G. Isolation of exosome-like vesicles from plants by ultracentrifugation on sucrose/deuterium oxide (D2O) density cushions. Methods Mol Biol. 2016;1459:259–269. doi:10.1007/978-1-4939-3804-9_18
   PubMedGoogle Scholar
• Tan S, Yang Y, Yang W, et al. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment. J Exp Clin Cancer Res. 2023;42(1):59. doi:10.1186/s13046-023-02634-z
   PubMed Web of Science ®Google Scholar
• Leidal AM, Debnath J. Emerging roles for the autophagy machinery in extracellular vesicle biogenesis and secretion. FASEB Bioadv. 2021;3(5):377–386. doi:10.1096/fba.2020-00138
   PubMedGoogle Scholar
• Xu L, Wu LF, Deng FY. Exosome: an emerging source of biomarkers for human diseases. Curr Mol Med. 2019;19(6):387–394. doi:10.2174/1566524019666190429144310
   PubMed Web of Science ®Google Scholar
• Gupta D, Liang X, Pavlova S, et al. Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging. J Extracell Vesicles. 2020;9(1):1800222. doi:10.1080/20013078.2020.1800222
   PubMed Web of Science ®Google Scholar
• Németh K, Varga Z, Lenzinger D, et al. Extracellular vesicle release and uptake by the liver under normo- and hyperlipidemia. Cell Mol Life Sci. 2021;78(23):7589–7604. doi:10.1007/s00018-021-03969-6
   PubMed Web of Science ®Google Scholar
• Basthi Mohan P, Rajpurohit S, Musunuri B, Bhat G, Lochan R, Shetty S. Exosomes in chronic liver disease. Clin Chim Acta. 2023;540:117215. doi:10.1016/j.cca.2022.117215
   PubMed Web of Science ®Google Scholar
• Gong J, Tu W, Liu J, Tian D. Hepatocytes: a key role in liver inflammation. Front Immunol. 2022;13:1083780. doi:10.3389/fimmu.2022.1083780
   PubMed Web of Science ®Google Scholar
• Thietart S, Rautou PE. Extracellular vesicles as biomarkers in liver diseases: a clinician’s point of view. J Hepatol. 2020;73(6):1507–1525. doi:10.1016/j.jhep.2020.07.014
   PubMed Web of Science ®Google Scholar
• Matsuura S, Nakada H, Sawamura T, Tashiro Y. Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface. J Cell Biol. 1982;95(3):864–875. doi:10.1083/jcb.95.3.864
   PubMed Web of Science ®Google Scholar
• Trere D, Fiume L, De Giorgi LB, Di Stefano G, Migaldi M, Derenzini M. The asialoglycoprotein receptor in human hepatocellular carcinomas:its expression on proliferating cells. Br J Cancer. 1999;81(3):404–408. doi:10.1038/sj.bjc.6690708
   PubMed Web of Science ®Google Scholar
• Hyodo I, Mizuno M, Yamada G, Tsuji T. Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma. Liver. 1993;13(2):80–85. doi:10.1111/j.1600-0676.1993.tb00611.x
   PubMedGoogle Scholar
• Shi B, Abrams M, Sepp-Lorenzino L. Expression of asialoglycoprotein receptor 1 in human hepatocellular carcinoma. J Histochem Cytochem. 2013;61(12):901–909. doi:10.1369/0022155413503662
   PubMed Web of Science ®Google Scholar
• Aydin Y, Koksal AR, Reddy V, et al. Extracellular vesicle release promotes viral replication during persistent HCV infection. Cells. 2021;10(5):984. doi:10.3390/cells10050984
   PubMed Web of Science ®Google Scholar
• Aydin Y, Koksal AR, Thevenot P, et al. Experimental validation of novel glypican 3 exosomes for the detection of hepatocellular carcinoma in liver cirrhosis. J Hepatocell Carcinoma. 2021;8:1579–1596. doi:10.2147/jhc.S327339
   PubMed Web of Science ®Google Scholar
• Aydin Y, Stephens CM, Chava S, et al. Chaperone-mediated autophagy promotes beclin1 degradation in persistently infected hepatitis C virus cell culture. Am J Pathol. 2018;188(10):2339–2355. doi:10.1016/j.ajpath.2018.06.022
   PubMed Web of Science ®Google Scholar
• Chava S, Lee C, Aydin Y, et al. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma. Oncotarget. 2017;8(25):40019–40036. doi:10.18632/oncotarget.16685
   PubMedGoogle Scholar
• Koksal AR, Thevenot P, Aydin Y, et al. Impaired autophagy response in Hepatocellular Carcinomas enriches glypican-3 in exosomes, not in the microvesicles. J Hepatocell Carcinoma. 2022;9:959–972. doi:10.2147/jhc.S376210
   PubMed Web of Science ®Google Scholar
• Bastos N, Ruivo CF, da Silva S, Melo SA. Exosomes in cancer: use them or target them? Semin Cell Dev Biol. 2018;78:13–21. doi:10.1016/j.semcdb.2017.08.009
   PubMed Web of Science ®Google Scholar
• Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta. 2014;1846(1):75–87. doi:10.1016/j.bbcan.2014.04.005
   PubMed Web of Science ®Google Scholar
• Kurian TK, Banik S, Gopal D, Chakrabarti S, Mazumder N. Elucidating methods for isolation and quantification of exosomes: a review. Mol Biotechnol. 2021;63(4):249–266. doi:10.1007/s12033-021-00300-3
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi:10.1080/20013078.2018.1535750
   PubMed Web of Science ®Google Scholar
• Koritzinsky EH, Street JM, Star RA, Yuen PS. Quantification of exosomes. J Cell Physiol. 2017;232(7):1587–1590. doi:10.1002/jcp.25387
   PubMed Web of Science ®Google Scholar
• Carnell-Morris P, Tannetta D, Siupa A, Hole P, Dragovic R. Analysis of extracellular vesicles using fluorescence nanoparticle tracking analysis. Methods Mol Biol. 2017;1660:153–173. doi:10.1007/978-1-4939-7253-1_13
   PubMedGoogle Scholar
• Griffiths D, Carnell-Morris P, Wright M. Nanoparticle tracking analysis for multiparameter characterization and counting of nanoparticle suspensions. Methods Mol Biol. 2020;2118:289–303. doi:10.1007/978-1-0716-0319-2_22
   PubMedGoogle Scholar
• Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine. 2011;7(6):780–788. doi:10.1016/j.nano.2011.04.003
   PubMed Web of Science ®Google Scholar
• Giebel B, Helmbrecht C. Methods to analyze EVs. Methods Mol Biol. 2017;1545:1–20. doi:10.1007/978-1-4939-6728-5_1
   PubMedGoogle Scholar
• Kestens V, Bozatzidis V, De Temmerman PJ, Ramaye Y, Roebben G. Validation of a particle tracking analysis method for the size determination of nano- and microparticles. J Nanopart Res. 2017;19(8):271. doi:10.1007/s11051-017-3966-8
   PubMed Web of Science ®Google Scholar
• Alberro A, Iparraguirre L, Fernandes A, Otaegui D. Extracellular vesicles in blood: sources, effects, and applications. Int J Mol Sci. 2021;22(15):8163. doi:10.3390/ijms22158163
   PubMed Web of Science ®Google Scholar
• Böing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3. doi: 10.3402/jev.v3.23430.
   Google Scholar
• Gámez-Valero A, Monguió-Tortajada M, Carreras-Planella L, Franquesa M, Beyer K, Borràs FE. Size-exclusion chromatography-based isolation minimally alters extracellular vesicles’ characteristics compared to precipitating agents. Sci Rep. 2016;6:33641. doi:10.1038/srep33641
   PubMed Web of Science ®Google Scholar
• Buratta S, Tancini B, Sagini K, et al. Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic- and endo-lysosomal systems go extracellular. Int J Mol Sci. 2020;21(7):2576. doi:10.3390/ijms21072576
   PubMed Web of Science ®Google Scholar
• Qiang L, Hu J, Tian M, et al. Extracellular vesicles from helicobacter pylori-infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis. Helicobacter. 2022;27(2):e12877. doi:10.1111/hel.12877
   PubMed Web of Science ®Google Scholar
• Xu J, Yang KC, Go NE, et al. Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations. Autophagy. 2022;18(11):2547–2560. doi:10.1080/15548627.2022.2039535
   PubMed Web of Science ®Google Scholar
• Li Y, He X, Li Q, et al. EV-origin: enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile. Comput Struct Biotechnol J. 2020;18:2851–2859. doi:10.1016/j.csbj.2020.10.002
   PubMed Web of Science ®Google Scholar
• Holcar M, Kandušer M, Lenassi M. Blood nanoparticles - influence on extracellular vesicle isolation and characterization. Front Pharmacol. 2021;12:773844. doi:10.3389/fphar.2021.773844
   PubMed Web of Science ®Google Scholar
• Karimi N, Dalirfardouei R, Dias T, Lötvall J, Lässer C. Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma - contributions of platelet extracellular vesicles in plasma samples. J Extracell Vesicles. 2022;11(5):e12213. doi:10.1002/jev2.12213
   PubMed Web of Science ®Google Scholar
• Minakaki G, Menges S, Kittel A, et al. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018;14(1):98–119. doi:10.1080/15548627.2017.1395992
   PubMed Web of Science ®Google Scholar
• Tayob N, Kanwal F, Alsarraj A, Hernaez R, El-Serag HB. The performance of AFP, AFP-3, DCP as biomarkers for detection of Hepatocellular Carcinoma (HCC): a Phase 3 biomarker study in the United States. Clin Gastroenterol Hepatol. 2023;21(2):415–423.e4. doi:10.1016/j.cgh.2022.01.047
   PubMed Web of Science ®Google Scholar
• Beudeker BJB, Fu S, Balderramo D, et al. Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin AMerica and Europe. Hepatol Commun. 2023;7(10):e0264. doi:10.1097/HC9.0264
   PubMed Web of Science ®Google Scholar
• Adeniji N, Dhanasekaran R. Current and emerging tools for Hepatocellular carcinoma surveillance. Hepatol Commun. 2021;5(12):1972–1986. doi:10.1002/hep4.1823
   PubMed Web of Science ®Google Scholar
• Chalasani NP, Ramasubramanian TS, Bhattacharya A, et al. A novel blood-based panel of methylated DNA and protein markers for detection of early-stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2021;19(12):2597–2605.e4. doi:10.1016/j.cgh.2020.08.065
   PubMed Web of Science ®Google Scholar
• Chan LK, Tsui YM, Ho DW, Ng IO. Cellular heterogeneity and plasticity in liver cancer. Semin Cancer Biol. 2022;82:134–149. doi:10.1016/j.semcancer.2021.02.015
   PubMed Web of Science ®Google Scholar
• Chen VL, Xu D, Wicha MS, Lok AS, Parikh ND. Utility of liquid biopsy analysis in detection of hepatocellular carcinoma, determination of prognosis, and disease monitoring: a systematic review. Clin Gastroenterol Hepatol. 2020;18(13):2879–2902.e9. doi:10.1016/j.cgh.2020.04.019
   PubMed Web of Science ®Google Scholar
• Sun N, Lee YT, Zhang RY, et al. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring. Nat Commun. 2020;11(1):4489. doi:10.1038/s41467-020-18311-0
   PubMed Web of Science ®Google Scholar
• Crosby D, Bhatia S, Brindle KM, et al. Early detection of cancer. Science. 2022;375(6586):eaay9040. doi:10.1126/science.aay9040
   PubMed Web of Science ®Google Scholar